Rostafuroxine

N/A

Report date: 2022/06/27 20:00:35
NME

Base Information

Drug NameRostafuroxine
Drug Alias NameRostafuroxin罗他福辛rostafuroxinum罗他夫辛rostafuroxine +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium/hydrogen exchanger 1 inhibitorsSodium/hydrogen exchanger 3 inhibitorsSodium/hydrogen exchanger 2 inhibitors +[4] 
TargetsSodium/hydrogen exchanger 2Sodium/hydrogen exchanger 5Sodium/hydrogen exchanger 1 +[4] 
Therapy Area/IndicationsEssential HypertensionHypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumTaiwanPoland +[6] 
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaIND
Originator CompaniesSigma-Tau Spa
China Registration ClassN/A

Develop Information

Active CompaniesLee'S Pharmaceutical (Hk) LtdPatheon Uk LtdZhaoke Pharmaceutical (Hefei) Co Ltd +[4] 
Inactive CompaniesWindtree Therapeutics IncSigma-Tau Ifr SpaRostaquo Spa
Active IndicationsHypertension
Inactive IndicationsEssential Hypertension

Other Information

ATC CodeN/A
Related LinksN/A